VEGFA and atrial fibrillation: While pharmacovigilance data have indicated an increased reporting of atrial fibrillation with anti-VEGF therapies (ROR > 1) [24], our patient had a long-standing history of recurrent atrial fibrillation, including prior ablation and cardioversion attempts.